varenicline has been researched along with Addiction, Opioid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, JH; Blank, MD; Dino, G; Felicione, NJ; Ozga, JE; Sullivan, CR | 1 |
| Cao, J; Jordan, CJ; Newman, AH; Xi, ZX | 1 |
| Martin, RA; Rohsenow, DJ; Tidey, JW | 1 |
| Arnsten, JH; Litwin, AH; Nahvi, S; Segal, KS | 1 |
| Hooten, WM; Warner, DO | 1 |
| Lewis, D; Theobald, J; Winhusen, T | 1 |
| Klein, JW | 1 |
| Arnsten, JH; Bernstein, SL; Nahvi, S; Richter, KP; Wu, B | 1 |
2 review(s) available for varenicline and Addiction, Opioid
| Article | Year |
|---|---|
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dextroamphetamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Development; Humans; Methadone; Methylphenidate; Modafinil; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxalates; Piperazines; Receptors, Opioid, mu; Tobacco Use Disorder; Tropanes; Varenicline | 2019 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
5 trial(s) available for varenicline and Addiction, Opioid
| Article | Year |
|---|---|
Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial.
Topics: Feasibility Studies; Humans; Opioid-Related Disorders; Outpatients; Smoking Cessation; Treatment Outcome; Varenicline | 2022 |
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.
Topics: Adult; Alcoholism; Comorbidity; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics.
Topics: Adult; Benzazepines; Cross-Sectional Studies; Directly Observed Therapy; Female; Follow-Up Studies; Humans; Male; Methadone; New York City; Opioid-Related Disorders; Pilot Projects; Quinoxalines; Research Design; Self Administration; Smoking; Smoking Cessation; Substance Abuse Treatment Centers; Varenicline | 2014 |
Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial.
Topics: Adult; Analgesics, Opioid; Benzazepines; Chronic Pain; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Opioid-Related Disorders; Pain Measurement; Pilot Projects; Quinoxalines; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2015 |
Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Clinical Protocols; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Research Design; Single-Blind Method; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2016 |
1 other study(ies) available for varenicline and Addiction, Opioid
| Article | Year |
|---|---|
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.
Topics: Benzazepines; Cardiovascular Diseases; Comorbidity; Data Interpretation, Statistical; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Nicotinic Agonists; Opioid-Related Disorders; Prevalence; Primary Health Care; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline | 2013 |